Tag: LB-100

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to LB-100

Lixte Biotechnology Announces the Closing of $4.19 Million Registered Direct Offering

Added to Collection on: 2021-03-02 15:22:30

Tags for this article:

Financial markets
73rd United States Congress
U.S. Securities and Exchange Commission
Finance
Initial public offering
Agencies of the United States government
Prospectus
Stock market
Securities Act
Forward-looking statement
Securities Exchange Act
United States Securities Regulation
Lixte Biotechnology Holdings Inc.
LB-100

Click the tags to see associated articles and topics

View Article Details
Lixte Biotechnology to Present Its Novel Product Candidate for Targeted Cancer Therapy at the ...

Added to Collection on: 2021-03-17 13:30:00

Tags for this article:

Cancer
Forward-looking statement
Articles
Lixte Biotechnology Holdings Inc.
S. Kovach, M.D.
LB-100

Click the tags to see associated articles and topics

View Article Details
Lixte Biotechnology to Discuss Pipeline of Clinical Investigations for Four Cancer Targets at the ...

Added to Collection on: 2021-04-28 13:30:00

Tags for this article:

Cancer
Treatment of cancer
Lixte Biotechnology Holdings Inc.
LB-100

Click the tags to see associated articles and topics

View Article Details
Lixte Biotechnology to Present Key Advantages of Novel Cancer Drug Candidate LB-100 at the ...

Added to Collection on: 2021-05-04 20:26:15

Tags for this article:

Health sciences
Health
Cancer
Communication
Forward-looking statement
Articles
Clinical trial
Lixte Biotechnology Holdings Inc.
S. Kovach, M.D.
LB-100
Sidoti & Company LLC

Click the tags to see associated articles and topics

View Article Details
Lixte Biotechnology Holdings, Inc. Reports Findings Show LIXTE's Lead Clinical Compound ...

Added to Collection on: 2024-06-06 13:58:37

Tags for this article:

Oncology
Immune system
Cancer vaccines
Immunology
Antigen
Biomolecules
Tumor antigen
Cancer treatment
Mutanome
Cancer/testis antigens
Lixte Biotechnology Holdings Inc.
LB-100

Click the tags to see associated articles and topics

View Article Details
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to ...

Added to Collection on: 2025-03-27 13:14:27

Tags for this article:

Cancer
Ovarian cancer
Virotherapy
Experimental cancer treatments
LB-100
Lixte Biotechnology Holdings Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo